SlateStone Wealth, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
SlateStone Wealth, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$274,000
-57.9%
14,447
-26.1%
0.06%
-60.4%
Q3 2021$651,000
-13.7%
19,547
+0.5%
0.15%
-13.4%
Q2 2021$754,000
-22.7%
19,447
-4.0%
0.17%
-28.6%
Q1 2021$976,000
+6.0%
20,247
+14.4%
0.24%
+4.8%
Q4 2020$921,000
+117.7%
17,697
+12.0%
0.23%
+152.7%
Q3 2020$423,000
+46.9%
15,797
+6.8%
0.09%
+42.2%
Q2 2020$288,00014,7970.06%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders